Vaccination remains one of the most effective methods for preventing infectious diseases; however, its traditional form—injections—often causes discomfort and fear in patients. In recent years, researchers have been actively seeking alternative methods for vaccine delivery into the human body that would be less invasive, more convenient, and potentially more effective. One of the most unexpected but promising directions has been the development of a vaccine delivered using ordinary dental floss. This innovation combines achievements in engineering, nanotechnology, and dental science, opening new prospects for population immunization.
A group of engineers and biomedical researchers from Texas Tech University has presented a unique method for administering vaccines without the use of needles. The essence of the method is that vaccine components are applied to dental floss, which is then gently guided along the gum line, coming into contact with the epithelial tissue—a thin, porous structure connecting the gum to the tooth and forming the base of the gingival sulcus. As is known, the mucous membrane is highly vascularized, especially in the area of the dentogingival attachment, where not only the processes of gingival fluid excretion and nutrient diffusion occur but also the activation of the local oral immunity. Due to the good blood supply of this layer, the delivered substances immediately enter the lymphoid structures and systemic circulation. Therefore, this vaccination method is relevant and appropriate for use. This natural “gateway” to the immune system has long attracted the attention of researchers, but its application for needle-free vaccine delivery has become a true innovation.
To transport the vaccine components and enhance the efficiency of delivery, the researchers used gold nanoparticles. These tiny structures, only 10–50 nanometers in size, possess high biocompatibility and practically cause no toxic reactions. On their surface, they can carry proteins, immunogenic peptides, and mRNA, protecting them from degradation in saliva and ensuring slow, controlled release. The shape and size of the nanoparticles have a decisive influence on the vaccine’s ability to penetrate the junctional epithelium, making this process both safe and effective.
The study utilized several types of vaccine substances. An inactivated virus served as a source of antigens without the risk of infection. Protein antigens and immunogenic peptides stimulated the production of specific antibodies and a T-cell response, while mRNA vaccines allowed the body’s cells to synthesize antigens independently, eliciting a powerful and long-term immune response. This combination of components ensured comprehensive activation of the immune system at both systemic and mucosal levels.
For a complete understanding of the picture, it is necessary to consider the pathochemical processes and the mechanism of immune activation during flossing with an immunized thread. After penetrating through the gingival epithelium, the vaccine components interact with mucosal cells, including dendritic cells and antibody-producing cells (IgA). This triggers a complex immune reaction: a local mucosal response and systemic production of IgG. As a result, the body develops long-term immunity capable of providing protection even when dietary conditions or age change. It is this multi-layered mechanism that ensured the outstanding results of the experiment.
The study involved 50 mice that underwent “flossing” with the vaccine-coated thread every two weeks for 28 days. The control group did not receive vaccination and was subjected to the same viral load. After being infected with a lethal strain of influenza, all vaccinated mice survived, whereas all control subjects died. This result convincingly demonstrates that floss-based vaccination induces a robust and effective immune response, comparable to traditional injection methods.
The researchers noted that vaccination using the thread triggered a powerful and sustained activation of the immune system across multiple organs, provided a strong systemic and mucosal immune response, and ensured long-term protection against infection, regardless of the animals’ age or their food and fluid intake. These data indicate the high efficacy of the new method compared to existing methods of mucosal immunization.
The method of needle-free vaccination reduces the risk of infections associated with injections and increases people’s willingness to get vaccinated, especially among children and patients with needle phobia. The possibility of delivering vaccines through the mucosa opens new horizons for the prevention of various infectious diseases, as well as for the administration of therapeutic proteins and other biomedical agents. The potential for targeted impact on the gingival epithelium creates prospects for the development of individualized immunotherapies adapted to the characteristics of a particular organism. Moreover, this approach could stimulate further research in the field of controlling local inflammation and preventing chronic oral diseases.
Thus, dental floss could transform from a common dental hygiene tool into an innovative means of immunization, uniting the achievements of nanotechnology, biomedicine, immunology, and dentistry in a unique interdisciplinary approach.
The field of oncological dentistry and primary dental care is undergoing a profound transformation requiring a new integration of clinical
Modern dentistry is developing under conditions of rapid growth in clinical capabilities. New materials, digital technologies, imaging methods, and treatment
OTEXE.COM uses cookies to personalize the services and improve the usability of the site. If you do not want to use cookies, please disable them in your browser settings.
